Challenges in AML
Keith Wilson, Victoria Potter
Johannes Schetelig, Mark Levis
April 16, 2024
Two comprehensive lectures on the different challenges in AML: professor Johannes Schetelig tackles the controversial subject of transplanting with residual/refractory AML while professor Mark Levis talks about drug maintenance strategies post allogeneic HCT.
Don’t miss the Q&A at the end of the recording.
Presentations
Drug maintenance strategies post allogeneic stem cell transplant - Mark Levis
Transplanting with residual/refractory disease - Johannes Schetelig
Featured presentations
Document